help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fuehrlein, B. S.
Right arrow Articles by Brantly, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fuehrlein, B. S.
Right arrow Articles by Brantly, M. L.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 4 1641-1645
Copyright © 2004 by The Endocrine Society

Differential Metabolic Effects of Saturated Versus Polyunsaturated Fats in Ketogenic Diets

Brian S. Fuehrlein, Michael S. Rutenberg, Jared N. Silver, Matthew W. Warren, Douglas W. Theriaque, Glen E. Duncan, Peter W. Stacpoole and Mark L. Brantly

Department of Medicine (Divisions of Endocrinology and Metabolism and Pulmonary Medicine) (M.L.B.) and General Clinical Research Center (B.S.F., M.S.R., J.N.S., M.W.W., D.W.T., P.W.S.), College of Medicine, University of Florida, Gainesville, Florida 32610; and Department of Epidemiology (G.E.D.), Nutritional Sciences Program, University of Washington, Seattle, Washington 98103

Address all correspondence and requests for reprints to: Dr. Mark L. Brantly, P.O. Box 100255, Gainesville, FL 32610-0255. E-mail: warren{at}ufl.edu.

Ketogenic diets (KDs) are used for treatment of refractory epilepsy and metabolic disorders. The classic saturated fatty acid-enriched (SAT) KD has a fat:carbohydrate plus protein ratio of 4:1, in which the predominant fats are saturated. We hypothesized that a polyunsaturated fat-enriched (POLY) KD would induce a similar degree of ketosis with less detrimental effects on carbohydrate and lipid metabolism. Twenty healthy adults were randomized to two different weight-maintaining KDs for 5 d. Diets were 70% fat, 15% carbohydrate, and 15% protein. The fat contents were 60 or 15% saturated, 15 or 60% polyunsaturated, and 25% monounsaturated for SAT and POLY, respectively. Changes in serum ß-hydroxybutyrate, insulin sensitivity (SI), and lipid profiles were measured. Mean circulating ß-hydroxybutyrate levels increased 8.4 mg/dl in the POLY group (P = 0.0004), compared with 3.1 mg/dl in the SAT group (P = 0.07). SI increased significantly in the POLY group (P = 0.02), whereas total and low-density lipoprotein cholesterol increased significantly in the SAT group (both P = 0.002). These data demonstrate that a short-term POLY KD induces a greater level of ketosis and improves SI, without adversely affecting total and low-density lipoprotein cholesterol, compared with a traditional SAT KD. Thus, a POLY KD may be superior to a classical SAT KD for chronic administration.

This study was supported by National Institutes of Health Grant M01-RR00082-41 to the GCRC.

B.S.F., M.S.R., J.N.S., and M.W.W. contributed equally to this work.

Abbreviations: BOHB, ß-Hydroxybutyrate; HDL, high-density lipoprotein; LDL, low-density lipoprotein; POLY, polyunsaturated fat-enriched; SAT, saturated fatty acid-enriched; SI, insulin sensitivity.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
N. J Krilanovich
Benefits of ketogenic diets
Am. J. Clinical Nutrition, January 1, 2007; 85(1): 238 - 239.
[Full Text] [PDF]


Home page
NeurologyHome page
T. B. VanItallie, C. Nonas, A. Di Rocco, K. Boyar, K. Hyams, and S. B. Heymsfield
Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study
Neurology, February 22, 2005; 64(4): 728 - 730.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society